MedTrace Logo

Management of Polycystic Ovarian Syndrome-associated Reproductive Dysfunction Through Kefir Supplementation

NCT07711782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-07-17

No results posted yet for this study

Summary

Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.

Conditions

  • Polycystic Ovarian Syndrome (PCOS)
  • Reproductive Health

Interventions

OTHER

(C0) Control group

Participants were subjected to use a regular calorie deficit diet plan

DIETARY_SUPPLEMENT

(G1) Experimental group

Participants were advised to take water 250ml of water kefir per day in their mid-morning snack time for 2 months.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-18
Primary Completion
2026-03-18
Completion
2026-04-18

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07711782 on ClinicalTrials.gov